Data Foundry

Medical device recalls 2014

SIEMENS ADVIA Centaur CP Immunoassay System BNP kit — Class II medical device recall Z-2149-2014

Terminated recall by Siemens Healthcare Diagnostics, Inc, reported 2014-08-13, distributed nationwide. Complaints of failed calibration.

Recall numberZ-2149-2014
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmSiemens Healthcare Diagnostics, Inc, East Walpole, MA, United States
Recall initiated2014-06-23
Classified2014-08-05
Reported by FDA2014-08-13
Terminated2016-03-31
DistributedNationwide (US)
Countries outside the USAE, AR, AT, AU, BG, BR, CA, CH, CL, CN, CO, CY, CZ, DE, DK, EE, EG, ES, FI, FR, GB, GR, HK, HR, HU, ID, IE, IL, IN, IQ, IR, IS, IT, JP, KR, LB, LT, LV, MY, NL, NO, OM, PH, PK, PL, PT, QA, RO, RS, SA, SE, SG, SI, SK, TH, TR, TW, UA, VE, VN, ZA
Quantity1,191 kits
Lot numbers38479172, 39181172

Product

SIEMENS ADVIA Centaur CP Immunoassay System BNP kit; SMN 10309044 - 100 test For in vitro diagnostic use in the quantitative determination of B-type Natriuretic Peptide (BNP) in human plasma using the ADVIA Centaur CP System.

Reason for recall

Complaints of failed calibration.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-2149-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.